From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery.Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. 
GWAS
From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery.Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. 
GWAS
From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery.Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. 
GWAS